Financials
| Half-year Report | Mar. 22, 2024 |
| Dermatonics Full Year trading update | Feb. 06, 2024 |
| Final Results | Nov. 30, 2023 |
| Acne study, Trading and Auditor updates | Oct. 25, 2023 |
| Replacement Half-year Report | Mar. 28, 2023 |
| Half-year Report | Mar. 28, 2023 |
| Final Results | Dec. 15, 2022 |
Proxies
| Result of AGM | Dec. 29, 2023 |
| Notice of AGM and posting of Annual Report | Dec. 06, 2023 |
| Results of AGM | Dec. 30, 2022 |
| Notice of AGM | Dec. 06, 2022 |
| Result of AGM | Dec. 23, 2021 |
| Annual General Meeting 2021 – Change of Venue | Dec. 21, 2021 |
| Result of AGM | Dec. 29, 2020 |
Ownership Update
| Holding(s) in Company | Mar. 18, 2024 |
| Holding(s) in Company | Nov. 23, 2023 |
| Holding(s) in Company | Jul. 31, 2023 |
| Director/PDMR Shareholding | Apr. 14, 2023 |
| Director/PDMR Shareholding | Mar. 09, 2023 |
| Director/PDMR Shareholding | Mar. 09, 2023 |
| Holding(s) in Company | Feb. 20, 2023 |
Announcements
| Closure of Convertible Bond Facility | Jul. 23, 2024 |
| Conversion Notice and Total Voting Rights | Jul. 22, 2024 |
| Notice of Business Update & Investor Presentation | Jul. 15, 2024 |
| Conversion Notice and Total Voting Rights | Jun. 28, 2024 |
| AxisBiotix Acne study reports positive data | Jun. 18, 2024 |
| Conversion Notice and Total Voting Rights | May. 29, 2024 |
| Conversion Notice & Total Voting Rights | Apr. 05, 2024 |